The FDA approved linaclotide (Linzess) capsules to treat irritable bowel syndrome with constipation (IBS-C) in children age 7 years and older, the agency announced Wednesday. The decision makes the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback